ArticleScience advances2022
Complement C3 inhibition in severe COVID-19 using compstatin AMY-101.
Panagiotis Skendros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this papercites it
ArticleScience advances2022
Panagiotis Skendros et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.